Evolus Phase III European – Canadian Head-to-Head Trial of prabotulinumtoxinA Compared to Botox® Meets Primary Endpoint Longevity Investing
Sonoma Pharmaceuticals Announces FDA Approval for Antimicrobial Post-Therapy Gel Life Science Investing
AC Immune Announces the Selection of Tau Small Molecules for Clinical Development in Alzheimer’s disease Biotech Investing
Align Technology Introduces Invisalign Clear Aligners for Phase 1 Treatment of Younger Patients With Early Mixed Dentition Medical Device Investing
Align Technology Extends Invisalign G5 Precision Bite Ramps to Vivera Retainers Medical Device Investing
Conatus Pharmaceuticals Announces Top-line Results from Phase 2b POLT-HCV-SVR Clinical Trial Pharmaceutical Investing
Paratek’s New Drug Applications for Oral and Intravenous Omadacycline Accepted for Priority Review by FDA Pharmaceutical Investing
Harvest One Converts all Outstanding Debentures to Ordinary Shares and Maintains $80m Cash Position Cannabis Investing News
